Clinical Trial Update: The Effect of Sitagliptin, Pioglitazone and Dapagliflozine on Myocardial Infarction in Diabetic Rats [Phase 4]

View source ↗

Summary

A Phase 4 animal study in diabetic rats evaluated the effects of sitagliptin, pioglitazone, and dapagliflozin on myocardial infarction outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Myocardial Infarction

Drugs mentioned

• Actos (Pioglitazone)
• Forxiga (dapagliflozin)
• Januvia (sitagliptin)

Snippet

Sponsor: Al-Azhar University | Conditions: Diabetic, Myocardial Infarction | Phase 4 | Status: COMPLETED